Deoxyribonucleases, antagonists & inhibitors
DBCAT006090Pharmacologic class
A DrugBank category of 1 drug. 1 of them is approved.
- Drugs
What you can answer from here — as of October 10, 2026
Which targets do Deoxyribonucleases, antagonists & inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account